Education
About Us
Working with TipRanks
Follow Us
ProtoKinetix (PKTX)
:PKTX
PKTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume47.78K
Average Volume (3M)38.95K
Market Cap
$3.42M
Enterprise Value$3.48M
Total Cash (Recent Filing)$49.48K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding388,580,140
10 Day Avg. Volume19,453
30 Day Avg. Volume38,947
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)9.04
Price to Sales (P/S)0.00
P/FCF Ratio-16.61
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue26.03
Enterprise Value/Gross Profit-267.43
Enterprise Value/Ebitda-2.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
22.04% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
77.96% Public Companies and
Individual Investors
PKTX FAQ
What was ProtoKinetix’s price range in the past 12 months?
ProtoKinetix lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is ProtoKinetix’s market cap?
ProtoKinetix’s market cap is $3.42M.
When is ProtoKinetix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProtoKinetix’s earnings last quarter?
ProtoKinetix released its earnings results on Apr 26, 2018. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is ProtoKinetix overvalued?
According to Wall Street analysts ProtoKinetix’s price is currently Overvalued.
Does ProtoKinetix pay dividends?
ProtoKinetix does not currently pay dividends.
What is ProtoKinetix’s EPS estimate?
ProtoKinetix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProtoKinetix have?
ProtoKinetix has 388,580,140 shares outstanding.
What happened to ProtoKinetix’s price movement after its last earnings report?
ProtoKinetix reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of ProtoKinetix?
Currently, no hedge funds are holding shares in PKTX
Company Description
ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
Technical Analysis
Creative Medical Technology Holdings
―
Silo Pharma
―
Spruce Biosciences
―
Longevity Health Holdings
―
Klotho Neurosciences
―